This inventor holds 1 USPTO granted patent. Top assignee: Australia Nuclear Science & Technology Organization. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Michael Shying - Innovator in Radiopharmaceutical Technology
Introduction
Michael Shying is a notable inventor based in Cronulla, Australia. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative patent related to the treatment of technetium-containing solutions. His work is essential for enhancing the purity and concentration of radiopharmaceuticals used in medical applications.
Latest Patents
Michael Shying holds a patent for the "Treatment of technetium containing solutions." This patent describes a method involving an initial aqueous pertechnetate solution with low electrolyte concentration. The process includes passing the solution through a bed of insoluble ion exchange material to adsorb the pertechnetate. Subsequently, an ionic eluant is used to remove the pertechnetate, resulting in a concentrated and pure eluate solution. The method is particularly valuable for treating eluates from portable technetium generators, ensuring the eluate has a suitable pH for radiopharmaceutical purposes. The ion exchange material used in this process is zirconium oxide, which effectively retains radionuclidic impurities.
Career Highlights
Michael Shying is associated with the Australia Nuclear Science & Technology Organization, where he applies his expertise in radiopharmaceutical technology. His innovative approach to treating technetium solutions has positioned him as a key figure in the field, contributing to advancements in medical imaging and treatment.
Collaborations
Michael has collaborated with esteemed colleagues, including John M Sodeau and John V Evans. Their combined efforts have furthered research and development in radiopharmaceutical applications, enhancing the effectiveness of medical diagnostics.
Conclusion
Michael Shying's contributions to the field of radiopharmaceuticals through his innovative patent demonstrate his commitment to advancing medical technology. His work not only improves the quality of radiopharmaceuticals but also plays a crucial role in enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile